These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21734220)

  • 1. Global asymptotic stability for HIV-1 dynamics with two distributed delays.
    Wang J; Huang G; Takeuchi Y
    Math Med Biol; 2012 Sep; 29(3):283-300. PubMed ID: 21734220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of delays in cell infection and virus production on HIV-1 dynamics.
    Zhu H; Zou X
    Math Med Biol; 2008 Jun; 25(2):99-112. PubMed ID: 18504248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global stability of an HIV-1 model with distributed intracellular delays and a combination therapy.
    Liu S; Wang L
    Math Biosci Eng; 2010 Jul; 7(3):675-85. PubMed ID: 20578792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global threshold dynamics in an HIV virus model with nonlinear infection rate and distributed invasion and production delays.
    Yuan Z; Zou X
    Math Biosci Eng; 2013 Apr; 10(2):483-98. PubMed ID: 23458310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nature of equilibria and effects of drug treatments in some simple viral population dynamical models.
    Tuckwell HC; Wan FY
    IMA J Math Appl Med Biol; 2000 Dec; 17(4):311-27. PubMed ID: 11270747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodic multidrug therapy in a within-host virus model.
    Browne CJ; Pilyugin SS
    Bull Math Biol; 2012 Mar; 74(3):562-89. PubMed ID: 21822766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of an HIV-1 therapy model of fighting a virus with another virus.
    Jiang X; Yu P; Yuan Z; Zou X
    J Biol Dyn; 2009 Jul; 3(4):387-409. PubMed ID: 22876940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A within-host virus model with periodic multidrug therapy.
    Wang Z; Zhao XQ
    Bull Math Biol; 2013 Mar; 75(3):543-63. PubMed ID: 23381930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global dynamics of an in-host viral model with intracellular delay.
    Li MY; Shu H
    Bull Math Biol; 2010 Aug; 72(6):1492-505. PubMed ID: 20087671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability analysis of a model for HIV infection with RTI and three intracellular delays.
    Ouifki R; Witten G
    Biosystems; 2009 Jan; 95(1):1-6. PubMed ID: 18706970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability analysis of within-host parasite models with delays.
    Iggidr A; Mbang J; Sallet G
    Math Biosci; 2007 Sep; 209(1):51-75. PubMed ID: 17383688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global stability for a class of HIV virus-to-cell dynamical model with Beddington-DeAngelis functional response and distributed time delay.
    Zhou XR; Zhang L; Zheng T; Li HL; Teng ZD
    Math Biosci Eng; 2020 Jun; 17(5):4527-4543. PubMed ID: 33120517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sveir epidemiological model with varying infectivity and distributed delays.
    Wang J; Huang G; Takeuchi Y; Liu S
    Math Biosci Eng; 2011 Jul; 8(3):875-88. PubMed ID: 21675816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of CTL immune response on HIV infection model with potent therapy, latently infected cells and cell-to-cell viral transmission.
    Guo T; Qiu ZP
    Math Biosci Eng; 2019 Jul; 16(6):6822-6841. PubMed ID: 31698590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global stability for epidemic model with constant latency and infectious periods.
    Huang G; Beretta E; Takeuchi Y
    Math Biosci Eng; 2012 Apr; 9(2):297-312. PubMed ID: 22901066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An age-structured within-host HIV-1 infection model with virus-to-cell and cell-to-cell transmissions.
    Xu R; Tian X; Zhang S
    J Biol Dyn; 2018 Dec; 12(1):89-117. PubMed ID: 29173134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells.
    Tsai WP; Conley SR; Kung HF; Garrity RR; Nara PL
    Virology; 1996 Dec; 226(2):205-16. PubMed ID: 8955040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and experience with reverse transcriptase inhibitors and protease inhibitors.
    Vella S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S58-61. PubMed ID: 8595511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.